Massmutual Trust Co. FSB ADV Has $633,000 Stock Position in Agilent Technologies, Inc. (NYSE:A)

Massmutual Trust Co. FSB ADV raised its position in Agilent Technologies, Inc. (NYSE:AGet Rating) by 1.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,332 shares of the medical research company’s stock after acquiring an additional 83 shares during the period. Massmutual Trust Co. FSB ADV’s holdings in Agilent Technologies were worth $633,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Bromfield Sneider Wealth Advisors bought a new stake in shares of Agilent Technologies in the 2nd quarter valued at approximately $31,000. Riverview Trust Co bought a new stake in shares of Agilent Technologies in the 1st quarter valued at approximately $33,000. Glassman Wealth Services grew its stake in shares of Agilent Technologies by 47.4% in the 4th quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock valued at $37,000 after purchasing an additional 74 shares during the period. Bank of New Hampshire bought a new stake in shares of Agilent Technologies in the 1st quarter valued at approximately $38,000. Finally, J.W. Cole Advisors Inc. grew its stake in shares of Agilent Technologies by 7,201.6% in the 1st quarter. J.W. Cole Advisors Inc. now owns 124,493 shares of the medical research company’s stock valued at $45,000 after purchasing an additional 122,788 shares during the period.

Analyst Ratings Changes

A has been the topic of several analyst reports. Wells Fargo & Company upped their price objective on Agilent Technologies from $130.00 to $135.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 17th. Evercore ISI increased their price target on Agilent Technologies to $145.00 in a research report on Monday, August 22nd. KeyCorp decreased their price target on Agilent Technologies from $195.00 to $155.00 and set an “overweight” rating on the stock in a research report on Thursday, June 2nd. UBS Group initiated coverage on Agilent Technologies in a research report on Wednesday, July 20th. They set a “buy” rating and a $139.00 price target on the stock. Finally, Citigroup increased their price target on Agilent Technologies from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 17th. Four equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $151.31.

Insider Activity

In other news, VP Padraig Mcdonnell sold 2,506 shares of the stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $134.33, for a total value of $336,630.98. Following the transaction, the vice president now owns 15,320 shares of the company’s stock, valued at approximately $2,057,935.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Agilent Technologies Stock Down 2.5 %

Shares of A opened at $129.89 on Friday. The firm has a market capitalization of $38.45 billion, a price-to-earnings ratio of 29.59, a PEG ratio of 2.62 and a beta of 1.06. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.41 and a current ratio of 1.94. The business’s fifty day moving average price is $129.92 and its two-hundred day moving average price is $127.15. Agilent Technologies, Inc. has a 52 week low of $112.52 and a 52 week high of $177.36.

Agilent Technologies (NYSE:AGet Rating) last posted its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The company had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.64 billion. Agilent Technologies had a return on equity of 28.46% and a net margin of 19.94%. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.10 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 5.07 earnings per share for the current year.

Agilent Technologies Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.